nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.045	0.0879	CbGbCtD
Conivaptan—CYP3A4—Trimethadione—epilepsy syndrome	0.0418	0.0817	CbGbCtD
Conivaptan—CYP3A4—Felbamate—epilepsy syndrome	0.0418	0.0817	CbGbCtD
Conivaptan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0393	0.0768	CbGbCtD
Conivaptan—CYP3A4—Clonazepam—epilepsy syndrome	0.0356	0.0694	CbGbCtD
Conivaptan—CYP3A4—Clobazam—epilepsy syndrome	0.0341	0.0666	CbGbCtD
Conivaptan—CYP3A4—Rufinamide—epilepsy syndrome	0.029	0.0566	CbGbCtD
Conivaptan—CYP3A4—Carbamazepine—epilepsy syndrome	0.0282	0.0552	CbGbCtD
Conivaptan—CYP3A4—Primidone—epilepsy syndrome	0.0264	0.0515	CbGbCtD
Conivaptan—CYP3A4—Phenytoin—epilepsy syndrome	0.0253	0.0495	CbGbCtD
Conivaptan—CYP3A4—Propofol—epilepsy syndrome	0.0236	0.0462	CbGbCtD
Conivaptan—CYP3A4—Acetazolamide—epilepsy syndrome	0.0226	0.0441	CbGbCtD
Conivaptan—CYP3A4—Phenobarbital—epilepsy syndrome	0.0226	0.0441	CbGbCtD
Conivaptan—CYP3A4—Midazolam—epilepsy syndrome	0.0223	0.0435	CbGbCtD
Conivaptan—CYP3A4—Diazepam—epilepsy syndrome	0.0214	0.0418	CbGbCtD
Conivaptan—CYP3A4—Zonisamide—epilepsy syndrome	0.0209	0.0408	CbGbCtD
Conivaptan—CYP3A4—Valproic Acid—epilepsy syndrome	0.0169	0.033	CbGbCtD
Conivaptan—CYP3A4—Topiramate—epilepsy syndrome	0.0152	0.0297	CbGbCtD
Conivaptan—Atorvastatin—SLCO1A2—epilepsy syndrome	0.00173	0.334	CrCbGaD
Conivaptan—Atorvastatin—ABCC2—epilepsy syndrome	0.000825	0.16	CrCbGaD
Conivaptan—Lomitapide—ABCB1—epilepsy syndrome	0.000697	0.135	CrCbGaD
Conivaptan—Tolvaptan—ABCB1—epilepsy syndrome	0.000622	0.12	CrCbGaD
Conivaptan—Atorvastatin—CYP2C19—epilepsy syndrome	0.000573	0.111	CrCbGaD
Conivaptan—Atorvastatin—CYP2D6—epilepsy syndrome	0.000425	0.0822	CrCbGaD
Conivaptan—Atorvastatin—ABCB1—epilepsy syndrome	0.000304	0.0587	CrCbGaD
Conivaptan—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000273	0.00098	CcSEcCtD
Conivaptan—Orthostatic hypotension—Topiramate—epilepsy syndrome	0.000272	0.000978	CcSEcCtD
Conivaptan—Infection—Carbamazepine—epilepsy syndrome	0.000272	0.000976	CcSEcCtD
Conivaptan—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.000271	0.000975	CcSEcCtD
Conivaptan—Hypokalaemia—Topiramate—epilepsy syndrome	0.000271	0.000975	CcSEcCtD
Conivaptan—Vomiting—Clobazam—epilepsy syndrome	0.000271	0.000974	CcSEcCtD
Conivaptan—Insomnia—Zonisamide—epilepsy syndrome	0.000271	0.000973	CcSEcCtD
Conivaptan—Pain—Diazepam—epilepsy syndrome	0.00027	0.000971	CcSEcCtD
Conivaptan—Constipation—Diazepam—epilepsy syndrome	0.00027	0.000971	CcSEcCtD
Conivaptan—Dry mouth—Lamotrigine—epilepsy syndrome	0.00027	0.000969	CcSEcCtD
Conivaptan—Body temperature increased—Levetiracetam—epilepsy syndrome	0.00027	0.000969	CcSEcCtD
Conivaptan—Hypotension—Clonazepam—epilepsy syndrome	0.00027	0.000968	CcSEcCtD
Conivaptan—Angiopathy—Valproic Acid—epilepsy syndrome	0.000268	0.000964	CcSEcCtD
Conivaptan—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000268	0.000964	CcSEcCtD
Conivaptan—Hypotension—Phenytoin—epilepsy syndrome	0.000268	0.000962	CcSEcCtD
Conivaptan—Headache—Clobazam—epilepsy syndrome	0.000267	0.00096	CcSEcCtD
Conivaptan—Confusional state—Lamotrigine—epilepsy syndrome	0.000267	0.000958	CcSEcCtD
Conivaptan—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000266	0.000957	CcSEcCtD
Conivaptan—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000266	0.000957	CcSEcCtD
Conivaptan—Skin disorder—Carbamazepine—epilepsy syndrome	0.000266	0.000954	CcSEcCtD
Conivaptan—Urinary tract infection—Gabapentin—epilepsy syndrome	0.000265	0.000953	CcSEcCtD
Conivaptan—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000264	0.00095	CcSEcCtD
Conivaptan—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.000264	0.000948	CcSEcCtD
Conivaptan—Oedema peripheral—Pregabalin—epilepsy syndrome	0.000263	0.000946	CcSEcCtD
Conivaptan—Infection—Lamotrigine—epilepsy syndrome	0.000263	0.000944	CcSEcCtD
Conivaptan—Urethral disorder—Pregabalin—epilepsy syndrome	0.000262	0.000941	CcSEcCtD
Conivaptan—Pain—Felbamate—epilepsy syndrome	0.000261	0.000939	CcSEcCtD
Conivaptan—Constipation—Felbamate—epilepsy syndrome	0.000261	0.000939	CcSEcCtD
Conivaptan—Nausea—Lacosamide—epilepsy syndrome	0.000261	0.000938	CcSEcCtD
Conivaptan—Insomnia—Clonazepam—epilepsy syndrome	0.000261	0.000937	CcSEcCtD
Conivaptan—Feeling abnormal—Diazepam—epilepsy syndrome	0.00026	0.000935	CcSEcCtD
Conivaptan—Haematuria—Gabapentin—epilepsy syndrome	0.00026	0.000935	CcSEcCtD
Conivaptan—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.00026	0.000935	CcSEcCtD
Conivaptan—Diarrhoea—Acetazolamide—epilepsy syndrome	0.00026	0.000934	CcSEcCtD
Conivaptan—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000259	0.000931	CcSEcCtD
Conivaptan—Insomnia—Phenytoin—epilepsy syndrome	0.000259	0.000931	CcSEcCtD
Conivaptan—Mental disorder—Valproic Acid—epilepsy syndrome	0.000259	0.000931	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000258	0.000928	CcSEcCtD
Conivaptan—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000258	0.000926	CcSEcCtD
Conivaptan—Malnutrition—Valproic Acid—epilepsy syndrome	0.000257	0.000925	CcSEcCtD
Conivaptan—Constipation—Zonisamide—epilepsy syndrome	0.000256	0.00092	CcSEcCtD
Conivaptan—Hypotension—Carbamazepine—epilepsy syndrome	0.000256	0.000918	CcSEcCtD
Conivaptan—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000254	0.000911	CcSEcCtD
Conivaptan—Nausea—Clobazam—epilepsy syndrome	0.000253	0.00091	CcSEcCtD
Conivaptan—Feeling abnormal—Felbamate—epilepsy syndrome	0.000252	0.000905	CcSEcCtD
Conivaptan—Pruritus—Propofol—epilepsy syndrome	0.00025	0.000897	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000249	0.000895	CcSEcCtD
Conivaptan—Cardiac disorder—Pregabalin—epilepsy syndrome	0.000248	0.000891	CcSEcCtD
Conivaptan—Insomnia—Carbamazepine—epilepsy syndrome	0.000247	0.000889	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000247	0.000889	CcSEcCtD
Conivaptan—Pain—Clonazepam—epilepsy syndrome	0.000247	0.000886	CcSEcCtD
Conivaptan—Constipation—Clonazepam—epilepsy syndrome	0.000247	0.000886	CcSEcCtD
Conivaptan—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000247	0.000886	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000246	0.000884	CcSEcCtD
Conivaptan—Constipation—Phenytoin—epilepsy syndrome	0.000245	0.00088	CcSEcCtD
Conivaptan—Pruritus—Midazolam—epilepsy syndrome	0.000244	0.000878	CcSEcCtD
Conivaptan—Pain—Oxcarbazepine—epilepsy syndrome	0.000244	0.000876	CcSEcCtD
Conivaptan—Constipation—Oxcarbazepine—epilepsy syndrome	0.000244	0.000876	CcSEcCtD
Conivaptan—Angiopathy—Pregabalin—epilepsy syndrome	0.000242	0.000871	CcSEcCtD
Conivaptan—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000242	0.00087	CcSEcCtD
Conivaptan—Body temperature increased—Felbamate—epilepsy syndrome	0.000242	0.000868	CcSEcCtD
Conivaptan—Vomiting—Acetazolamide—epilepsy syndrome	0.000242	0.000868	CcSEcCtD
Conivaptan—Diarrhoea—Propofol—epilepsy syndrome	0.000242	0.000868	CcSEcCtD
Conivaptan—Oedema peripheral—Gabapentin—epilepsy syndrome	0.000241	0.000867	CcSEcCtD
Conivaptan—Pruritus—Levetiracetam—epilepsy syndrome	0.000241	0.000867	CcSEcCtD
Conivaptan—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000241	0.000865	CcSEcCtD
Conivaptan—Urethral disorder—Gabapentin—epilepsy syndrome	0.00024	0.000863	CcSEcCtD
Conivaptan—Insomnia—Lamotrigine—epilepsy syndrome	0.000239	0.000859	CcSEcCtD
Conivaptan—Headache—Acetazolamide—epilepsy syndrome	0.000238	0.000856	CcSEcCtD
Conivaptan—Pollakiuria—Topiramate—epilepsy syndrome	0.000238	0.000855	CcSEcCtD
Conivaptan—Anaemia—Valproic Acid—epilepsy syndrome	0.000238	0.000855	CcSEcCtD
Conivaptan—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000238	0.000854	CcSEcCtD
Conivaptan—Body temperature increased—Zonisamide—epilepsy syndrome	0.000237	0.00085	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000236	0.000848	CcSEcCtD
Conivaptan—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000236	0.000848	CcSEcCtD
Conivaptan—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000235	0.000844	CcSEcCtD
Conivaptan—Mental disorder—Pregabalin—epilepsy syndrome	0.000234	0.000841	CcSEcCtD
Conivaptan—Constipation—Carbamazepine—epilepsy syndrome	0.000234	0.00084	CcSEcCtD
Conivaptan—Pain—Carbamazepine—epilepsy syndrome	0.000234	0.00084	CcSEcCtD
Conivaptan—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000233	0.000839	CcSEcCtD
Conivaptan—Pruritus—Fosphenytoin—epilepsy syndrome	0.000233	0.000837	CcSEcCtD
Conivaptan—Malnutrition—Pregabalin—epilepsy syndrome	0.000233	0.000836	CcSEcCtD
Conivaptan—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000232	0.000835	CcSEcCtD
Conivaptan—Pneumonia—Topiramate—epilepsy syndrome	0.000231	0.00083	CcSEcCtD
Conivaptan—Infestation—Topiramate—epilepsy syndrome	0.00023	0.000825	CcSEcCtD
Conivaptan—Infestation NOS—Topiramate—epilepsy syndrome	0.00023	0.000825	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000228	0.00082	CcSEcCtD
Conivaptan—Body temperature increased—Clonazepam—epilepsy syndrome	0.000228	0.000819	CcSEcCtD
Conivaptan—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000227	0.000817	CcSEcCtD
Conivaptan—Pruritus—Vigabatrin—epilepsy syndrome	0.000227	0.000816	CcSEcCtD
Conivaptan—Body temperature increased—Phenytoin—epilepsy syndrome	0.000227	0.000814	CcSEcCtD
Conivaptan—Pain—Lamotrigine—epilepsy syndrome	0.000226	0.000812	CcSEcCtD
Conivaptan—Constipation—Lamotrigine—epilepsy syndrome	0.000226	0.000812	CcSEcCtD
Conivaptan—Nausea—Acetazolamide—epilepsy syndrome	0.000226	0.000811	CcSEcCtD
Conivaptan—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000225	0.00081	CcSEcCtD
Conivaptan—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000225	0.00081	CcSEcCtD
Conivaptan—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000225	0.000809	CcSEcCtD
Conivaptan—Vomiting—Propofol—epilepsy syndrome	0.000224	0.000807	CcSEcCtD
Conivaptan—Pruritus—Diazepam—epilepsy syndrome	0.000224	0.000803	CcSEcCtD
Conivaptan—Urinary tract infection—Topiramate—epilepsy syndrome	0.000223	0.000802	CcSEcCtD
Conivaptan—Hypertension—Valproic Acid—epilepsy syndrome	0.000222	0.000798	CcSEcCtD
Conivaptan—Headache—Propofol—epilepsy syndrome	0.000221	0.000795	CcSEcCtD
Conivaptan—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000221	0.000794	CcSEcCtD
Conivaptan—Vomiting—Midazolam—epilepsy syndrome	0.00022	0.000789	CcSEcCtD
Conivaptan—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00022	0.000789	CcSEcCtD
Conivaptan—Haematuria—Topiramate—epilepsy syndrome	0.000219	0.000787	CcSEcCtD
Conivaptan—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000218	0.000783	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000218	0.000782	CcSEcCtD
Conivaptan—Vomiting—Levetiracetam—epilepsy syndrome	0.000217	0.000779	CcSEcCtD
Conivaptan—Headache—Midazolam—epilepsy syndrome	0.000216	0.000777	CcSEcCtD
Conivaptan—Pruritus—Felbamate—epilepsy syndrome	0.000216	0.000777	CcSEcCtD
Conivaptan—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000216	0.000777	CcSEcCtD
Conivaptan—Diarrhoea—Diazepam—epilepsy syndrome	0.000216	0.000777	CcSEcCtD
Conivaptan—Anaemia—Pregabalin—epilepsy syndrome	0.000215	0.000773	CcSEcCtD
Conivaptan—Mental disorder—Gabapentin—epilepsy syndrome	0.000215	0.000771	CcSEcCtD
Conivaptan—Dry mouth—Valproic Acid—epilepsy syndrome	0.000214	0.00077	CcSEcCtD
Conivaptan—Headache—Levetiracetam—epilepsy syndrome	0.000214	0.000768	CcSEcCtD
Conivaptan—Malnutrition—Gabapentin—epilepsy syndrome	0.000213	0.000767	CcSEcCtD
Conivaptan—Erythema—Gabapentin—epilepsy syndrome	0.000213	0.000767	CcSEcCtD
Conivaptan—Confusional state—Valproic Acid—epilepsy syndrome	0.000212	0.000761	CcSEcCtD
Conivaptan—Pruritus—Zonisamide—epilepsy syndrome	0.000212	0.000761	CcSEcCtD
Conivaptan—Nausea—Propofol—epilepsy syndrome	0.00021	0.000753	CcSEcCtD
Conivaptan—Vomiting—Fosphenytoin—epilepsy syndrome	0.000209	0.000752	CcSEcCtD
Conivaptan—Diarrhoea—Felbamate—epilepsy syndrome	0.000209	0.000752	CcSEcCtD
Conivaptan—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000209	0.000751	CcSEcCtD
Conivaptan—Infection—Valproic Acid—epilepsy syndrome	0.000209	0.00075	CcSEcCtD
Conivaptan—Headache—Fosphenytoin—epilepsy syndrome	0.000206	0.000741	CcSEcCtD
Conivaptan—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000206	0.00074	CcSEcCtD
Conivaptan—Nausea—Midazolam—epilepsy syndrome	0.000205	0.000737	CcSEcCtD
Conivaptan—Diarrhoea—Zonisamide—epilepsy syndrome	0.000205	0.000736	CcSEcCtD
Conivaptan—Pruritus—Clonazepam—epilepsy syndrome	0.000204	0.000733	CcSEcCtD
Conivaptan—Vomiting—Vigabatrin—epilepsy syndrome	0.000204	0.000733	CcSEcCtD
Conivaptan—Skin disorder—Valproic Acid—epilepsy syndrome	0.000204	0.000733	CcSEcCtD
Conivaptan—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000204	0.000732	CcSEcCtD
Conivaptan—Oedema peripheral—Topiramate—epilepsy syndrome	0.000203	0.00073	CcSEcCtD
Conivaptan—Pruritus—Phenytoin—epilepsy syndrome	0.000203	0.000728	CcSEcCtD
Conivaptan—Nausea—Levetiracetam—epilepsy syndrome	0.000203	0.000728	CcSEcCtD
Conivaptan—Urethral disorder—Topiramate—epilepsy syndrome	0.000202	0.000726	CcSEcCtD
Conivaptan—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000202	0.000724	CcSEcCtD
Conivaptan—Headache—Vigabatrin—epilepsy syndrome	0.000201	0.000722	CcSEcCtD
Conivaptan—Hypertension—Pregabalin—epilepsy syndrome	0.000201	0.000722	CcSEcCtD
Conivaptan—Vomiting—Diazepam—epilepsy syndrome	0.000201	0.000722	CcSEcCtD
Conivaptan—Headache—Diazepam—epilepsy syndrome	0.000198	0.000711	CcSEcCtD
Conivaptan—Diarrhoea—Clonazepam—epilepsy syndrome	0.000197	0.000709	CcSEcCtD
Conivaptan—Anaemia—Gabapentin—epilepsy syndrome	0.000197	0.000709	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000197	0.000707	CcSEcCtD
Conivaptan—Hypotension—Valproic Acid—epilepsy syndrome	0.000196	0.000705	CcSEcCtD
Conivaptan—Diarrhoea—Phenytoin—epilepsy syndrome	0.000196	0.000704	CcSEcCtD
Conivaptan—Nausea—Fosphenytoin—epilepsy syndrome	0.000196	0.000703	CcSEcCtD
Conivaptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000195	0.000701	CcSEcCtD
Conivaptan—Vomiting—Felbamate—epilepsy syndrome	0.000194	0.000699	CcSEcCtD
Conivaptan—Dry mouth—Pregabalin—epilepsy syndrome	0.000194	0.000696	CcSEcCtD
Conivaptan—Pruritus—Carbamazepine—epilepsy syndrome	0.000193	0.000695	CcSEcCtD
Conivaptan—Headache—Felbamate—epilepsy syndrome	0.000192	0.000688	CcSEcCtD
Conivaptan—Confusional state—Pregabalin—epilepsy syndrome	0.000191	0.000688	CcSEcCtD
Conivaptan—Cardiac disorder—Topiramate—epilepsy syndrome	0.000191	0.000688	CcSEcCtD
Conivaptan—Nausea—Vigabatrin—epilepsy syndrome	0.000191	0.000685	CcSEcCtD
Conivaptan—Vomiting—Zonisamide—epilepsy syndrome	0.00019	0.000684	CcSEcCtD
Conivaptan—Insomnia—Valproic Acid—epilepsy syndrome	0.00019	0.000683	CcSEcCtD
Conivaptan—Infection—Pregabalin—epilepsy syndrome	0.000189	0.000678	CcSEcCtD
Conivaptan—Nausea—Diazepam—epilepsy syndrome	0.000188	0.000674	CcSEcCtD
Conivaptan—Headache—Zonisamide—epilepsy syndrome	0.000188	0.000674	CcSEcCtD
Conivaptan—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000187	0.000672	CcSEcCtD
Conivaptan—Angiopathy—Topiramate—epilepsy syndrome	0.000187	0.000672	CcSEcCtD
Conivaptan—Pruritus—Lamotrigine—epilepsy syndrome	0.000187	0.000672	CcSEcCtD
Conivaptan—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000186	0.000669	CcSEcCtD
Conivaptan—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000186	0.000668	CcSEcCtD
Conivaptan—Skin disorder—Pregabalin—epilepsy syndrome	0.000184	0.000663	CcSEcCtD
Conivaptan—Hypertension—Gabapentin—epilepsy syndrome	0.000184	0.000662	CcSEcCtD
Conivaptan—Vomiting—Clonazepam—epilepsy syndrome	0.000183	0.000659	CcSEcCtD
Conivaptan—Vomiting—Phenytoin—epilepsy syndrome	0.000182	0.000655	CcSEcCtD
Conivaptan—Nausea—Felbamate—epilepsy syndrome	0.000182	0.000653	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000181	0.000652	CcSEcCtD
Conivaptan—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000181	0.000651	CcSEcCtD
Conivaptan—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000181	0.00065	CcSEcCtD
Conivaptan—Headache—Clonazepam—epilepsy syndrome	0.000181	0.000649	CcSEcCtD
Conivaptan—Mental disorder—Topiramate—epilepsy syndrome	0.000181	0.000649	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.00018	0.000648	CcSEcCtD
Conivaptan—Pain—Valproic Acid—epilepsy syndrome	0.00018	0.000645	CcSEcCtD
Conivaptan—Constipation—Valproic Acid—epilepsy syndrome	0.00018	0.000645	CcSEcCtD
Conivaptan—Headache—Phenytoin—epilepsy syndrome	0.000179	0.000645	CcSEcCtD
Conivaptan—Erythema—Topiramate—epilepsy syndrome	0.000179	0.000645	CcSEcCtD
Conivaptan—Malnutrition—Topiramate—epilepsy syndrome	0.000179	0.000645	CcSEcCtD
Conivaptan—Headache—Oxcarbazepine—epilepsy syndrome	0.000179	0.000642	CcSEcCtD
Conivaptan—Nausea—Zonisamide—epilepsy syndrome	0.000178	0.000639	CcSEcCtD
Conivaptan—Dry mouth—Gabapentin—epilepsy syndrome	0.000178	0.000638	CcSEcCtD
Conivaptan—Hypotension—Pregabalin—epilepsy syndrome	0.000177	0.000638	CcSEcCtD
Conivaptan—Confusional state—Gabapentin—epilepsy syndrome	0.000176	0.000631	CcSEcCtD
Conivaptan—Vomiting—Carbamazepine—epilepsy syndrome	0.000174	0.000625	CcSEcCtD
Conivaptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000173	0.000622	CcSEcCtD
Conivaptan—Infection—Gabapentin—epilepsy syndrome	0.000173	0.000622	CcSEcCtD
Conivaptan—Insomnia—Pregabalin—epilepsy syndrome	0.000172	0.000617	CcSEcCtD
Conivaptan—Nausea—Clonazepam—epilepsy syndrome	0.000171	0.000616	CcSEcCtD
Conivaptan—Headache—Carbamazepine—epilepsy syndrome	0.000171	0.000616	CcSEcCtD
Conivaptan—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000171	0.000614	CcSEcCtD
Conivaptan—Nausea—Phenytoin—epilepsy syndrome	0.00017	0.000611	CcSEcCtD
Conivaptan—Nausea—Oxcarbazepine—epilepsy syndrome	0.000169	0.000608	CcSEcCtD
Conivaptan—Skin disorder—Gabapentin—epilepsy syndrome	0.000169	0.000608	CcSEcCtD
Conivaptan—Vomiting—Lamotrigine—epilepsy syndrome	0.000168	0.000604	CcSEcCtD
Conivaptan—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000166	0.000597	CcSEcCtD
Conivaptan—Anaemia—Topiramate—epilepsy syndrome	0.000166	0.000596	CcSEcCtD
Conivaptan—Headache—Lamotrigine—epilepsy syndrome	0.000166	0.000595	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000164	0.000589	CcSEcCtD
Conivaptan—Hypotension—Gabapentin—epilepsy syndrome	0.000163	0.000585	CcSEcCtD
Conivaptan—Nausea—Carbamazepine—epilepsy syndrome	0.000162	0.000584	CcSEcCtD
Conivaptan—Constipation—Pregabalin—epilepsy syndrome	0.000162	0.000583	CcSEcCtD
Conivaptan—Pain—Pregabalin—epilepsy syndrome	0.000162	0.000583	CcSEcCtD
Conivaptan—Insomnia—Gabapentin—epilepsy syndrome	0.000157	0.000566	CcSEcCtD
Conivaptan—Nausea—Lamotrigine—epilepsy syndrome	0.000157	0.000564	CcSEcCtD
Conivaptan—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000156	0.000562	CcSEcCtD
Conivaptan—Hypertension—Topiramate—epilepsy syndrome	0.000155	0.000557	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000152	0.000545	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.00015	0.00054	CcSEcCtD
Conivaptan—Body temperature increased—Pregabalin—epilepsy syndrome	0.00015	0.000539	CcSEcCtD
Conivaptan—Dry mouth—Topiramate—epilepsy syndrome	0.000149	0.000537	CcSEcCtD
Conivaptan—Pain—Gabapentin—epilepsy syndrome	0.000149	0.000535	CcSEcCtD
Conivaptan—Constipation—Gabapentin—epilepsy syndrome	0.000149	0.000535	CcSEcCtD
Conivaptan—Pruritus—Valproic Acid—epilepsy syndrome	0.000149	0.000534	CcSEcCtD
Conivaptan—Confusional state—Topiramate—epilepsy syndrome	0.000148	0.000531	CcSEcCtD
Conivaptan—Infection—Topiramate—epilepsy syndrome	0.000146	0.000523	CcSEcCtD
Conivaptan—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000144	0.000516	CcSEcCtD
Conivaptan—Nervous system disorder—Topiramate—epilepsy syndrome	0.000144	0.000516	CcSEcCtD
Conivaptan—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000143	0.000516	CcSEcCtD
Conivaptan—Skin disorder—Topiramate—epilepsy syndrome	0.000142	0.000511	CcSEcCtD
Conivaptan—Body temperature increased—Gabapentin—epilepsy syndrome	0.000138	0.000495	CcSEcCtD
Conivaptan—Hypotension—Topiramate—epilepsy syndrome	0.000137	0.000492	CcSEcCtD
Conivaptan—Pruritus—Pregabalin—epilepsy syndrome	0.000134	0.000483	CcSEcCtD
Conivaptan—Vomiting—Valproic Acid—epilepsy syndrome	0.000134	0.00048	CcSEcCtD
Conivaptan—Insomnia—Topiramate—epilepsy syndrome	0.000132	0.000476	CcSEcCtD
Conivaptan—Headache—Valproic Acid—epilepsy syndrome	0.000132	0.000473	CcSEcCtD
Conivaptan—Diarrhoea—Pregabalin—epilepsy syndrome	0.00013	0.000467	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000126	0.000454	CcSEcCtD
Conivaptan—Constipation—Topiramate—epilepsy syndrome	0.000125	0.00045	CcSEcCtD
Conivaptan—Pain—Topiramate—epilepsy syndrome	0.000125	0.00045	CcSEcCtD
Conivaptan—Nausea—Valproic Acid—epilepsy syndrome	0.000125	0.000448	CcSEcCtD
Conivaptan—Pruritus—Gabapentin—epilepsy syndrome	0.000123	0.000443	CcSEcCtD
Conivaptan—Vomiting—Pregabalin—epilepsy syndrome	0.000121	0.000434	CcSEcCtD
Conivaptan—Feeling abnormal—Topiramate—epilepsy syndrome	0.000121	0.000434	CcSEcCtD
Conivaptan—Diarrhoea—Gabapentin—epilepsy syndrome	0.000119	0.000428	CcSEcCtD
Conivaptan—Headache—Pregabalin—epilepsy syndrome	0.000119	0.000427	CcSEcCtD
Conivaptan—Body temperature increased—Topiramate—epilepsy syndrome	0.000116	0.000416	CcSEcCtD
Conivaptan—Nausea—Pregabalin—epilepsy syndrome	0.000113	0.000405	CcSEcCtD
Conivaptan—Vomiting—Gabapentin—epilepsy syndrome	0.000111	0.000398	CcSEcCtD
Conivaptan—Headache—Gabapentin—epilepsy syndrome	0.000109	0.000392	CcSEcCtD
Conivaptan—Pruritus—Topiramate—epilepsy syndrome	0.000104	0.000372	CcSEcCtD
Conivaptan—Nausea—Gabapentin—epilepsy syndrome	0.000103	0.000372	CcSEcCtD
Conivaptan—Diarrhoea—Topiramate—epilepsy syndrome	0.0001	0.00036	CcSEcCtD
Conivaptan—Vomiting—Topiramate—epilepsy syndrome	9.31e-05	0.000335	CcSEcCtD
Conivaptan—Headache—Topiramate—epilepsy syndrome	9.18e-05	0.00033	CcSEcCtD
Conivaptan—Nausea—Topiramate—epilepsy syndrome	8.7e-05	0.000313	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—GRM1—epilepsy syndrome	7.03e-05	0.000344	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDYN—epilepsy syndrome	7.03e-05	0.000344	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CNR1—epilepsy syndrome	7.03e-05	0.000344	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PLCB1—epilepsy syndrome	7e-05	0.000342	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CHRM1—epilepsy syndrome	6.98e-05	0.000341	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDYN—epilepsy syndrome	6.98e-05	0.000341	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR7—epilepsy syndrome	6.98e-05	0.000341	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GRM1—epilepsy syndrome	6.98e-05	0.000341	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR7—epilepsy syndrome	6.91e-05	0.000338	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR7—epilepsy syndrome	6.86e-05	0.000335	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HBEGF—epilepsy syndrome	6.71e-05	0.000328	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HBEGF—epilepsy syndrome	6.66e-05	0.000325	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CDC42—epilepsy syndrome	6.61e-05	0.000323	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GFAP—epilepsy syndrome	6.61e-05	0.000323	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GAL—epilepsy syndrome	6.61e-05	0.000323	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT3—epilepsy syndrome	6.58e-05	0.000322	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CDC42—epilepsy syndrome	6.57e-05	0.000321	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GFAP—epilepsy syndrome	6.57e-05	0.000321	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GAL—epilepsy syndrome	6.57e-05	0.000321	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GRM5—epilepsy syndrome	6.54e-05	0.00032	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CHRM3—epilepsy syndrome	6.54e-05	0.00032	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP2—epilepsy syndrome	6.54e-05	0.00032	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT3—epilepsy syndrome	6.54e-05	0.000319	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CHRM3—epilepsy syndrome	6.49e-05	0.000317	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP2—epilepsy syndrome	6.49e-05	0.000317	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GRM5—epilepsy syndrome	6.49e-05	0.000317	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AVP—epilepsy syndrome	6.4e-05	0.000313	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AVP—epilepsy syndrome	6.36e-05	0.000311	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CX3CR1—epilepsy syndrome	6.27e-05	0.000306	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CX3CR1—epilepsy syndrome	6.22e-05	0.000304	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CX3CL1—epilepsy syndrome	6.15e-05	0.0003	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BDKRB1—epilepsy syndrome	6.15e-05	0.0003	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CHRM2—epilepsy syndrome	6.15e-05	0.0003	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BDKRB1—epilepsy syndrome	6.1e-05	0.000298	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CHRM2—epilepsy syndrome	6.1e-05	0.000298	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CX3CL1—epilepsy syndrome	6.1e-05	0.000298	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CDC42—epilepsy syndrome	6.01e-05	0.000294	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GABBR1—epilepsy syndrome	5.98e-05	0.000292	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CDC42—epilepsy syndrome	5.96e-05	0.000291	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GABBR1—epilepsy syndrome	5.94e-05	0.00029	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AVP—epilepsy syndrome	5.81e-05	0.000284	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AVP—epilepsy syndrome	5.77e-05	0.000282	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRH3—epilepsy syndrome	5.73e-05	0.00028	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRH3—epilepsy syndrome	5.69e-05	0.000278	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OPRM1—epilepsy syndrome	5.64e-05	0.000276	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OPRM1—epilepsy syndrome	5.6e-05	0.000274	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	5.44e-05	0.000266	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCR5—epilepsy syndrome	5.41e-05	0.000264	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR3—epilepsy syndrome	5.33e-05	0.000261	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.33e-05	0.00026	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR3—epilepsy syndrome	5.29e-05	0.000259	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.29e-05	0.000259	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.28e-05	0.000258	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPY—epilepsy syndrome	5.19e-05	0.000254	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	5.19e-05	0.000254	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPY—epilepsy syndrome	5.16e-05	0.000252	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ATP2A2—epilepsy syndrome	5.16e-05	0.000252	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AGT—epilepsy syndrome	5.05e-05	0.000247	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AGT—epilepsy syndrome	5.02e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL2—epilepsy syndrome	5.01e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HSPB1—epilepsy syndrome	5.01e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OXT—epilepsy syndrome	5.01e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CRH—epilepsy syndrome	5.01e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL3—epilepsy syndrome	5.01e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HSPB1—epilepsy syndrome	4.98e-05	0.000243	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CRH—epilepsy syndrome	4.98e-05	0.000243	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL3—epilepsy syndrome	4.98e-05	0.000243	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OXT—epilepsy syndrome	4.98e-05	0.000243	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL2—epilepsy syndrome	4.98e-05	0.000243	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCR5—epilepsy syndrome	4.94e-05	0.000242	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCR5—epilepsy syndrome	4.91e-05	0.00024	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	4.84e-05	0.000236	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2A—epilepsy syndrome	4.8e-05	0.000235	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.67e-05	0.000228	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TSC1—epilepsy syndrome	4.66e-05	0.000228	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTK2B—epilepsy syndrome	4.66e-05	0.000228	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.64e-05	0.000227	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TSC1—epilepsy syndrome	4.63e-05	0.000226	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTK2B—epilepsy syndrome	4.63e-05	0.000226	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AGT—epilepsy syndrome	4.59e-05	0.000224	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AGT—epilepsy syndrome	4.56e-05	0.000223	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR2—epilepsy syndrome	4.53e-05	0.000222	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SST—epilepsy syndrome	4.53e-05	0.000222	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NTRK2—epilepsy syndrome	4.53e-05	0.000222	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NTRK2—epilepsy syndrome	4.5e-05	0.00022	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR2—epilepsy syndrome	4.5e-05	0.00022	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SST—epilepsy syndrome	4.5e-05	0.00022	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—DUSP6—epilepsy syndrome	4.49e-05	0.00022	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—DUSP6—epilepsy syndrome	4.46e-05	0.000218	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	4.44e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLAT—epilepsy syndrome	4.42e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.4e-05	0.000215	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLAT—epilepsy syndrome	4.38e-05	0.000214	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.32e-05	0.000211	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL12—epilepsy syndrome	4.26e-05	0.000208	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	4.26e-05	0.000208	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—POMC—epilepsy syndrome	4.25e-05	0.000208	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	4.24e-05	0.000207	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	4.23e-05	0.000207	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.23e-05	0.000207	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL12—epilepsy syndrome	4.23e-05	0.000207	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	4.22e-05	0.000206	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—POMC—epilepsy syndrome	4.22e-05	0.000206	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.21e-05	0.000206	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	4.21e-05	0.000206	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.19e-05	0.000205	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CNR1—epilepsy syndrome	4.18e-05	0.000204	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JUNB—epilepsy syndrome	4.18e-05	0.000204	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.17e-05	0.000204	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLCB1—epilepsy syndrome	4.17e-05	0.000204	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JUNB—epilepsy syndrome	4.15e-05	0.000203	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CNR1—epilepsy syndrome	4.15e-05	0.000203	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.15e-05	0.000203	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLCB1—epilepsy syndrome	4.14e-05	0.000202	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR7—epilepsy syndrome	4.08e-05	0.000199	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR7—epilepsy syndrome	4.05e-05	0.000198	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HBEGF—epilepsy syndrome	3.96e-05	0.000194	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HBEGF—epilepsy syndrome	3.93e-05	0.000192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT3—epilepsy syndrome	3.89e-05	0.00019	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—POMC—epilepsy syndrome	3.86e-05	0.000189	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT3—epilepsy syndrome	3.86e-05	0.000189	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—POMC—epilepsy syndrome	3.84e-05	0.000188	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADAM10—epilepsy syndrome	3.8e-05	0.000186	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.8e-05	0.000186	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—epilepsy syndrome	3.78e-05	0.000185	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADAM10—epilepsy syndrome	3.77e-05	0.000184	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—epilepsy syndrome	3.75e-05	0.000183	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.74e-05	0.000183	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—S100B—epilepsy syndrome	3.59e-05	0.000176	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—S100B—epilepsy syndrome	3.57e-05	0.000174	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SOCS3—epilepsy syndrome	3.56e-05	0.000174	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDC42—epilepsy syndrome	3.55e-05	0.000173	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SOCS3—epilepsy syndrome	3.53e-05	0.000173	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDC42—epilepsy syndrome	3.52e-05	0.000172	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.5e-05	0.000171	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AVP—epilepsy syndrome	3.43e-05	0.000168	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AVP—epilepsy syndrome	3.41e-05	0.000167	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HES1—epilepsy syndrome	3.25e-05	0.000159	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HES1—epilepsy syndrome	3.22e-05	0.000158	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FYN—epilepsy syndrome	3.16e-05	0.000154	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—H2AFX—epilepsy syndrome	3.15e-05	0.000154	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MEF2C—epilepsy syndrome	3.14e-05	0.000154	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FYN—epilepsy syndrome	3.14e-05	0.000153	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—H2AFX—epilepsy syndrome	3.12e-05	0.000153	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MEF2C—epilepsy syndrome	3.12e-05	0.000152	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	3.04e-05	0.000148	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.01e-05	0.000147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NGF—epilepsy syndrome	3e-05	0.000147	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NGF—epilepsy syndrome	2.98e-05	0.000146	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.92e-05	0.000143	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR5—epilepsy syndrome	2.9e-05	0.000142	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.9e-05	0.000142	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.86e-05	0.00014	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2A—epilepsy syndrome	2.84e-05	0.000139	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TSC2—epilepsy syndrome	2.72e-05	0.000133	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGT—epilepsy syndrome	2.71e-05	0.000133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TSC2—epilepsy syndrome	2.7e-05	0.000132	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGT—epilepsy syndrome	2.69e-05	0.000132	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—epilepsy syndrome	2.66e-05	0.00013	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—epilepsy syndrome	2.64e-05	0.000129	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KDR—epilepsy syndrome	2.6e-05	0.000127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KDR—epilepsy syndrome	2.58e-05	0.000126	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.51e-05	0.000122	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.5e-05	0.000122	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCB—epilepsy syndrome	2.49e-05	0.000122	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6ST—epilepsy syndrome	2.48e-05	0.000121	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—epilepsy syndrome	2.28e-05	0.000112	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—epilepsy syndrome	2.27e-05	0.000111	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—epilepsy syndrome	2.23e-05	0.000109	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—epilepsy syndrome	2.22e-05	0.000108	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.19e-05	0.000107	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.19e-05	0.000107	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.19e-05	0.000107	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.19e-05	0.000107	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.19e-05	0.000107	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.19e-05	0.000107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGF2—epilepsy syndrome	2.02e-05	9.87e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.01e-05	9.81e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.01e-05	9.81e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.01e-05	9.81e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.01e-05	9.81e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF2—epilepsy syndrome	2e-05	9.79e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RELA—epilepsy syndrome	1.87e-05	9.16e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.87e-05	9.12e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.87e-05	9.12e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RELA—epilepsy syndrome	1.86e-05	9.09e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.86e-05	9.09e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.84e-05	8.98e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MTOR—epilepsy syndrome	1.82e-05	8.92e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.75e-05	8.57e-05	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.71e-05	8.34e-05	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.69e-05	8.28e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.69e-05	8.26e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP3—epilepsy syndrome	1.68e-05	8.2e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.66e-05	8.13e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.66e-05	8.13e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.66e-05	8.13e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.66e-05	8.13e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.66e-05	8.13e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JUN—epilepsy syndrome	1.64e-05	8.02e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JUN—epilepsy syndrome	1.63e-05	7.97e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.6e-05	7.81e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—epilepsy syndrome	1.59e-05	7.75e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.55e-05	7.57e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—epilepsy syndrome	1.54e-05	7.52e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.52e-05	7.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.52e-05	7.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.52e-05	7.43e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SRC—epilepsy syndrome	1.47e-05	7.2e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.46e-05	7.16e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SRC—epilepsy syndrome	1.46e-05	7.15e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.43e-05	7.01e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—epilepsy syndrome	1.42e-05	6.96e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.41e-05	6.91e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.41e-05	6.91e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.33e-05	6.5e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.29e-05	6.32e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.26e-05	6.16e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.26e-05	6.16e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.2e-05	5.88e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.2e-05	5.88e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.18e-05	5.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.15e-05	5.63e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.13e-05	5.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.11e-05	5.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.04e-05	5.07e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.01e-05	4.92e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—epilepsy syndrome	9.15e-06	4.47e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.11e-06	4.45e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.11e-06	4.45e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—epilepsy syndrome	9.08e-06	4.44e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.43e-06	3.63e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.24e-06	3.54e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.19e-06	3.52e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.49e-06	3.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.18e-06	3.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.15e-06	3.01e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.87e-06	2.87e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.81e-06	2.84e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TH—epilepsy syndrome	5.79e-06	2.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.83e-06	2.36e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.77e-06	2.33e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.64e-06	2.27e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.31e-06	2.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.78e-06	1.85e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.7e-06	1.81e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.18e-06	1.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.9e-06	1.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.54e-06	1.24e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.28e-06	6.23e-06	CbGpPWpGaD
